Common co-morbid conditions associated with type 2 diabetes mellitus

被引:0
|
作者
Shaha, Kartick Chanda [1 ]
Rahman, Md Shamsur [2 ]
Shahnaz, Tasmin [3 ]
Habibunnahar [4 ]
机构
[1] Dhaka Natl Med Coll, Dept Pharmacol, Dhaka, Bangladesh
[2] Dhaka Natl Med Coll, Dept Biochem, Dhaka, Bangladesh
[3] Ibn Sina Med Coll, Pharmacol Dept, Dhaka, Bangladesh
[4] Marks Med Coll, Pharmacol Dept, Dhaka, Bangladesh
来源
BANGLADESH JOURNAL OF MEDICAL SCIENCE | 2020年 / 19卷 / 02期
关键词
Co-morbid condition; Diabetes mellitus;
D O I
10.3329/bjms.v19i2.45001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The aim of the present study was to find out the common co-morbid conditions associated with type 2 diabetes mellitus. Methods: A descriptive, cross sectional study was conducted from January 2016 to June 2016 among 300 patients attending at Medicine outpatient department of the Community Based Medical College Hospital and Endocrine outpatient department of the Mymensingh Medical College Hospital after obtaining requisite consent from the patients. Data were collected through the interviewing of the patients. The collected data were entered into the computer and analyzed by using SPSS (version 20.1) to know the common co-morbid conditions associated with type 2 diabetes mellitus. The study was approved by the institutional ethical committee. Results: In a pool of 300 type 2 diabetics, Most of the patients (57.3%) belonged to the middle age group 41-60 years. More than half of the respondents were female (n=223, 74.3%). Among 300 cases, 188 patients had shown association with different co-morbid conditions. Female patients (77%) suffered from more co-morbid conditions than male patients (23%). Hypertension was the most commonly associated disease (65.42%) with DM. Conclusion: Most of the diabetic patients have co-morbid conditions. Hypertension was the most commonly associated disease with DM.
引用
收藏
页码:237 / 239
页数:3
相关论文
共 50 条
  • [21] When patients with diabetes are hospitalized for co-morbid conditions, can diabetes care be improved?
    Roman, SH
    Chassin, MR
    DIABETES, 2000, 49 : A223 - A223
  • [22] Co-morbid depression and diabetes distress among patients with type-2 diabetes in an Irish cohort
    Michalec, O. M.
    Haugh, S.
    Morrissey, M.
    Tun, T. Kyaw
    McDermott, J. H.
    Sreenan, S.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2019, 188 : S239 - S240
  • [23] To Assess The Co-relation of Diabetes Mellitus and Co-Morbid Tuberculosis on the leukocyte and platelet counts
    Aweis, Daud
    Suleiman, Syed Azhar Syed
    Mutlif, Abdul Razak
    ARCHIVES OF PHARMACY PRACTICE, 2010, 1 (01) : 12 - 14
  • [24] TENSION-TYPE HEADACHES AND CO-MORBID CONDITIONS IN CHILDREN AND ADOLESCENTS
    Nesterovskiy, Y.
    Zavadenko, N.
    Shipilova, E.
    CEPHALALGIA, 2016, 36 : 85 - 85
  • [25] CO-MORBID GOUT IS ASSOCIATED WITH INCREASED CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH TYPE 2 DIABETES, BUT NOT CARDIOVASCULAR EVENTS OR MORTALITY
    Mian, M.
    Patel, S.
    Wai, B.
    Srivastava, P.
    Buchanan, R.
    Burrell, L.
    INTERNAL MEDICINE JOURNAL, 2017, 47 : 13 - 13
  • [26] CO-MORBID GOUT IS ASSOCIATED WITH INCREASED CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH TYPE 2 DIABETES, BUT NOT CARDIOVASCULAR EVENTS OR MORTALITY
    Mian, M.
    Patel, S. K.
    Wai, B.
    Srivastava, P. M.
    Buchanan, R. R. C.
    Burrell, L. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 377 - 377
  • [27] Guideline for Adherence and Diabetes Control in Co-Morbid Conditions in a Tertiary Hospital in Malaysia
    Iqbal, M. Z.
    Khan, A. H.
    Sulaiman, S. A.
    Iqbal, M. S.
    Hussain, Z.
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2014, 13 (10) : 1739 - 1744
  • [28] Polypharmacy and Combination Therapy in the Management of Hypertension in Elderly Patients with Co-Morbid Diabetes Mellitus
    Mark A. Munger
    Drugs & Aging, 2010, 27 : 871 - 883
  • [29] TREATMENT OF DEPRESSION AND DIABETES WHEN CO-MORBID
    van der Feltz-Cornelis, C.
    EUROPEAN PSYCHIATRY, 2010, 25
  • [30] Prevalence of co-morbid conditions and concomitant medication use among type-2 diabetes patients in a state medicaid population
    Kavookjian, J
    Mody, R
    Kalsekar, I
    Iyer, S
    Rajagopalan, R
    Pawar, V
    VALUE IN HEALTH, 2005, 8 (03) : 352 - 352